Literature DB >> 2187298

Morphometrically estimated variation in nuclear size. A useful tool in grading prostatic cancer.

J H Blom1, F J Ten Kate, F H Schroeder, R O van der Heul.   

Abstract

At present there are several grading systems for prostatic carcinoma. Most are difficult to reproduce. An objective method of grading seems to be necessary and could make comparisons between various groups of patients easier and grading more reliable. In the present study morphometrically estimated nuclear size and variation in nuclear size are matched with the survival rates of 207 patients who underwent total perineal prostatectomy for cancer. On the basis of morphometrically estimated variation in nuclear size the patients could be divided into two groups with significantly differing survival rates. In this way it was possible to split the group of patients with grade 2 carcinoma (Mostofi's grading system) into two groups of patients with significantly different survival rates. The survival rates in these two groups did not differ significantly from those in the patients with Grade 1 and Grade 3 tumors respectively. The results are discussed in the light of the recent literature on the subject. Morphometry seems to be a valuable tool in grading prostatic cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2187298     DOI: 10.1007/bf00302467

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  10 in total

1.  Preliminary studies of histologic prognosis in cancer of the prostate.

Authors:  M Harada; F K Mostofi; D K Corle; D P Byar; B F Trump
Journal:  Cancer Treat Rep       Date:  1977 Mar-Apr

2.  Problems of grading carcinoma of prostate.

Authors:  F K Mostofi
Journal:  Semin Oncol       Date:  1976-06       Impact factor: 4.929

3.  Grading of prostatic carcinoma.

Authors:  F K Mostofi
Journal:  Cancer Chemother Rep       Date:  1975 Jan-Feb

4.  Grading of prostatic cancer: III. Multivariate analysis of prognostic parameters.

Authors:  F H Schroeder; W C Hop; J H Blom; F K Mostofi
Journal:  Prostate       Date:  1985       Impact factor: 4.104

5.  Well differentiated adenocarcinoma of the prostate.

Authors:  W H Kern
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

6.  A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness.

Authors:  D A Diamond; S J Berry; H J Jewett; J C Eggleston; D S Coffey
Journal:  J Urol       Date:  1982-10       Impact factor: 7.450

7.  [Reflexions on prostata carcinomas with regard to histomorphology and cytomorphometry (author's transl)].

Authors:  U Stöber; U Schnaidt
Journal:  Urol Int       Date:  1980       Impact factor: 2.089

8.  Nuclear roundness factor. A predictor of progression in untreated Stage A2 prostate cancer.

Authors:  J I Epstein; S J Berry; J C Eggleston
Journal:  Cancer       Date:  1984-10-15       Impact factor: 6.860

9.  Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer.

Authors:  D A Diamond; S J Berry; C Umbricht; H J Jewett; D S Coffey
Journal:  Prostate       Date:  1982       Impact factor: 4.104

10.  Grading of prostatic cancer (I): An analysis of the prognostic significance of single characteristics.

Authors:  F H Schroeder; J H Blom; W C Hop; F K Mostofi
Journal:  Prostate       Date:  1985       Impact factor: 4.104

  10 in total
  3 in total

1.  A Cell-Free Assay Using Xenopus laevis Embryo Extracts to Study Mechanisms of Nuclear Size Regulation.

Authors:  Lisa J Edens; Daniel L Levy
Journal:  J Vis Exp       Date:  2016-08-08       Impact factor: 1.355

2.  Organ-specific enhancement of metastasis by spontaneous ploidy duplication and cell size enlargement.

Authors:  Xin Lu; Xuemin Lu; Yibin Kang
Journal:  Cell Res       Date:  2010-07-13       Impact factor: 25.617

3.  cPKC regulates interphase nuclear size during Xenopus development.

Authors:  Lisa J Edens; Daniel L Levy
Journal:  J Cell Biol       Date:  2014-08-18       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.